Literature DB >> 29958565

When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease.

Jacinth J Joseph1, Allistair A Abraham2, Courtney D Fitzhugh3.   

Abstract

Many patients with sickle cell disease experience severe morbidity and early mortality. The only curative option remains hematopoietic stem cell transplantation. Although HLA-matched sibling transplantation has been very successful for adults and children, the vast majority of patients with sickle cell disease do not have an HLA-matched sibling. Alternative donor options include haploidentical, unrelated umbilical cord blood, and matched unrelated donor transplantation. This report summarizes major alternative donor transplantation studies reported to date and ongoing and upcoming clinical trials. We conclude that when there is no HLA-match, all these approaches should be systematically considered before ruling out the option of hematopoietic stem cell transplantation. Published by Elsevier Inc.

Entities:  

Keywords:  Alternative donor transplant; Haploidentical; Matched unrelated donor; Sickle cell disease; Umbilical cord blood

Mesh:

Year:  2018        PMID: 29958565     DOI: 10.1053/j.seminhematol.2018.04.013

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  6 in total

Review 1.  How I treat sickle cell disease with hematopoietic cell transplantation.

Authors:  Elizabeth O Stenger; Shalini Shenoy; Lakshmanan Krishnamurti
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

2.  HLA-DQB1 mismatch increase risk of severe bleeding independently in recipients of allogeneic stem cell transplant.

Authors:  Jiaqian Qi; Rui Zhang; Chengsen Cai; Hong Wang; Meng Zhou; Wenhong Shen; Yaqiong Tang; Tingting Pan; Depei Wu; Yue Han
Journal:  Ann Hematol       Date:  2021-04-12       Impact factor: 3.673

3.  Sickle cell disease in the era of precision medicine: looking to the future.

Authors:  Martin H Steinberg; Sara Kumar; George J Murphy; Kim Vanuytsel
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-11-07

Review 4.  Gene therapy for sickle cell disease: moving from the bench to the bedside.

Authors:  Allistair A Abraham; John F Tisdale
Journal:  Blood       Date:  2021-09-16       Impact factor: 25.476

Review 5.  Research in Sickle Cell Disease: From Bedside to Bench to Bedside.

Authors:  Gabriel Salinas Cisneros; Swee Lay Thein
Journal:  Hemasphere       Date:  2021-06-01

Review 6.  Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update.

Authors:  Dilan A Patel; Adeseye M Akinsete; Josu de la Fuente; Adetola A Kassim
Journal:  Hematol Oncol Stem Cell Ther       Date:  2020-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.